Jmcgh and Other sites: Non-Urine
Sites Only
Numbers are
percent susceptible
|
Gram
Negative Organisms |
No. of isolates |
amk |
am/s |
cz |
fep |
caz |
cx |
esbl (+) |
etp |
gm |
le |
mer |
tmp/ smx |
|
Acinetobacter baumannii |
79 |
- |
82 |
- |
39 |
25 |
- |
- |
- |
62 |
33 |
85 |
41 |
|
Citrobacter freundii |
9* |
100 |
- |
0 |
100 |
78 |
89 |
- |
100 |
89 |
89 |
100 |
78 |
|
Citrobacter koseri |
19* |
100 |
- |
100 |
100 |
100 |
100 |
- |
100 |
100 |
84 |
100 |
79 |
|
Enterobacter aerogenes |
18* |
100 |
- |
0 |
100 |
94 |
94 |
- |
100 |
100 |
100 |
100 |
100 |
|
Enterobacter cloacae |
52 |
100 |
- |
0 |
94 |
74 |
70 |
- |
92 |
91 |
89 |
100 |
81 |
|
Escherichia coli |
349 |
99 |
46 |
83 |
90 |
89 |
90 |
10 |
100 |
79 |
49 |
100 |
61 |
|
Klebsiella oxytoca |
22* |
100 |
96 |
87 |
100 |
100 |
100 |
0 |
100 |
91 |
91 |
100 |
91 |
|
Klebsiella pneumoniae |
129 |
98 |
85 |
90 |
92 |
92 |
92 |
7 |
99 |
95 |
92 |
99 |
85 |
|
Morganella morganii |
49 |
100 |
0 |
0 |
94 |
63 |
94 |
- |
100 |
78 |
57 |
100 |
49 |
|
Proteus mirabilis |
265 |
100 |
59 |
91 |
98 |
98 |
98 |
- |
100 |
79 |
35 |
100 |
37 |
|
Providencia stuartii |
28* |
100 |
0 |
0 |
100 |
93 |
100 |
- |
- |
36 |
21 |
100 |
29 |
|
Pseudomonas aeruginosa |
323 |
99 |
- |
- |
75 |
77 |
- |
- |
- |
72 |
55 |
76 |
- |
|
Serratia marcescens |
34 |
100 |
- |
0 |
100 |
100 |
100 |
- |
100 |
97 |
85 |
100 |
94 |
|
Stenotrophomonas maltophilia |
37 |
- |
- |
- |
- |
- |
- |
- |
- |
|
81 |
- |
95 |
*NO. of isolates-“Percent susceptible for each
organism/antimicrobial combination was generated by including the first isolate
of that organism recovered from a given patient.” When fewer that 30 isolates
are reported it should be noted that less than statistical validity of the
estimates of percent susceptibility exist.
Abbreviation Key: amk- amikacin,
am/s-ampicillin/sulbactam, cz-cefazolin, fep- cefepime, caz-ceftazidime,
cx-ceftriaxone, esbl-Extended
Spectrum Beta Lactamase, etp-ertapenem, gm-gentamicin, le-levofloxacin,
mer-Meropenem nit-nitrofurantoin,
pip/taz-piperacillin/tazobactam, tmp/smx-trimethoprim/sulfa
- antibiotics not tested or not
recommended due to lack of correlation between in vitro results and in vivo
activity.
Comments:
·
66% of Haemophilus infuenzae isolates were beta lactamase
negative (97 isolates tested). Beta Lactamase
negative indicates probable susceptibility to penicillin, ampicillin
and 1st generation cephalosporins. Beta lactamase positive indicates probable resistance to ampicillin, amoxicillin and first generation cephalosporins. Recommended therapy is combination therapy
or a third generation cephalosporin.
·
97% of Moraxella (Branhamella) catarrhalis
were beta lactamase positive (34 isolates tested).
Beta lactamase positive indicates resistance to
penicillin, ampicillin and first generation cephalosporins. Several beta-lactams
are effective including beta lactam/Beta Lactamase inhibitory combinations, 3rd
generation cephalosporins, macrolides,
quinolones and trimethoprim/sulfamethoxazole.
·
59 isolates of Salmonella species and 4 Shigella species were recovered.
Susceptibility testing is not routinely performed on intestinal sites. Extraintestinal sites are tested against ampicillin, trimethoprim/sulfa
and a third generation cephalosporin. Intestinal source isolates will be tested
per telephone request.
·
14 Campylobacter species were isolated
in 2010.
·
7 Giardia lamblia positive rapid antigens were confirmed in
2010.
·
1 Cryptosporidium positive rapid antigens
were confirmed in 2010.